| Idiopathic pulmonary fibrosis: Disease mechanisms and drug development P Spagnolo, JA Kropski, MG Jones, JS Lee, G Rossi, T Karampitsakos, ... Pharmacology & therapeutics 222, 107798, 2021 | 302 | 2021 |
| Lung cancer in patients with idiopathic pulmonary fibrosis T Karampitsakos, V Tzilas, R Tringidou, P Steiropoulos, V Aidinis, ... Pulmonary pharmacology & therapeutics 45, 1-10, 2017 | 167 | 2017 |
| Vitamin D prevents experimental lung fibrosis and predicts survival in patients with idiopathic pulmonary fibrosis V Tzilas, E Bouros, I Barbayianni, T Karampitsakos, S Kourtidou, ... Pulmonary Pharmacology & Therapeutics 55, 17-24, 2019 | 90 | 2019 |
| Mesenchymal stem cells for the treatment of idiopathic pulmonary fibrosis A Tzouvelekis, R Toonkel, T Karampitsakos, K Medapalli, I Ninou, ... Frontiers in Medicine 5, 142, 2018 | 86 | 2018 |
| Toll-like receptors in the pathogenesis of pulmonary fibrosis T Karampitsakos, T Woolard, D Bouros, A Tzouvelekis European journal of pharmacology 808, 35-43, 2017 | 77 | 2017 |
| Safety and efficacy of nintedanib in idiopathic pulmonary fibrosis: a real-life observational study in Greece A Tzouvelekis, T Karampitsakos, M Kontou, A Granitsas, I Malliou, ... Pulmonary pharmacology & therapeutics 49, 61-66, 2018 | 65 | 2018 |
| Safety and efficacy of pirfenidone in severe idiopathic pulmonary fibrosis: a real-world observational study A Tzouvelekis, P Ntolios, T Karampitsakos, V Tzilas, S Anevlavis, ... Pulmonary Pharmacology & Therapeutics 46, 48-53, 2017 | 58 | 2017 |
| Longitudinal “real-world” outcomes of pirfenidone in idiopathic pulmonary fibrosis in Greece A Tzouvelekis, T Karampitsakos, P Ntolios, V Tzilas, E Bouros, ... Frontiers in medicine 4, 213, 2017 | 53 | 2017 |
| Increased monocyte count and red cell distribution width as prognostic biomarkers in patients with Idiopathic Pulmonary Fibrosis T Karampitsakos, S Torrisi, K Antoniou, E Manali, I Korbila, ... Respiratory research 22 (1), 140, 2021 | 49 | 2021 |
| Precision medicine advances in idiopathic pulmonary fibrosis T Karampitsakos, BM Juan-Guardela, A Tzouvelekis, JD Herazo-Maya EBioMedicine 95, 2023 | 44 | 2023 |
| Metabolic disorders in chronic lung diseases O Papaioannou, T Karampitsakos, I Barbayianni, S Chrysikos, ... Frontiers in medicine 4, 246, 2018 | 42 | 2018 |
| Lung cancer in patients with idiopathic pulmonary fibrosis. A retrospective multicenter study in Greece A Tzouvelekis, T Karampitsakos, G Gomatou, E Bouros, V Tzilas, E Manali, ... Pulmonary pharmacology & therapeutics 60, 101880, 2020 | 36 | 2020 |
| Increased red cell distribution width is associated with disease severity in hospitalized adults with SARS-CoV-2 infection: an observational multicentric study T Karampitsakos, K Akinosoglou, O Papaioannou, V Panou, A Koromilias, ... Frontiers in medicine 7, 616292, 2020 | 34 | 2020 |
| Impact of depression on patients with idiopathic pulmonary fibrosis A Tzouvelekis, T Karampitsakos, S Kourtidou, E Bouros, V Tzilas, ... Frontiers in medicine 7, 29, 2020 | 34 | 2020 |
| Diagnostic value of BAL lymphocytosis in patients with indeterminate for usual interstitial pneumonia imaging pattern V Tzilas, A Tzouvelekis, E Bouros, T Karampitsakos, M Ntasiou, ... European Respiratory Journal 54 (5), 2019 | 34 | 2019 |
| Lung cancer in patients with idiopathic pulmonary fibrosis: a retrospective multicentre study in Europe T Karampitsakos, P Spagnolo, N Mogulkoc, WA Wuyts, S Tomassetti, ... Respirology 28 (1), 56-65, 2023 | 33 | 2023 |
| Greek physicians’ perceptions on generic drugs in the era of austerity G Labiris, M Fanariotis, C Kastanioti, G Alexias, A Protopapas, ... Scientifica 2015 (1), 251792, 2015 | 33 | 2015 |
| The DIAMORFOSIS (DIAgnosis and Management Of lung canceR and FibrOSIS) survey: international survey and call for consensus A Tzouvelekis, K Antoniou, M Kreuter, M Evison, TG Blum, V Poletti, ... ERJ Open Research 7 (1), 2021 | 32 | 2021 |
| Tocilizumab versus baricitinib in hospitalized patients with severe COVID-19: an open label, randomized controlled trial T Karampitsakos, O Papaioannou, P Tsiri, M Katsaras, A Katsimpris, ... Clinical Microbiology and Infection 29 (3), 372-378, 2023 | 31 | 2023 |
| Biologic treatments in interstitial lung diseases T Karampitsakos, A Vraka, D Bouros, SN Liossis, A Tzouvelekis Frontiers in medicine 6, 41, 2019 | 31 | 2019 |
DEMOSTHENES BOUROSNational and Kapodistrian University of Athens, School of Medicine在 med.uoa.gr 的电子邮件经过验证
